Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group. [electronic resource]
Producer: 20000301Description: 1058-64 p. digitalISSN:- 0390-6078
- Adult
- Aged
- Aged, 80 and over
- Drug Therapy, Combination
- Erythropoietin -- administration & dosage
- Female
- Follow-Up Studies
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Male
- Middle Aged
- Myelodysplastic Syndromes -- drug therapy
- Patient Compliance
- Predictive Value of Tests
- Recombinant Proteins -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase IV; Controlled Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.